Estimated Doses to the Heart, Lungs and Oesophagus and Risks From Typical UK Radiotherapy for Early Breast Cancer During 2015-2023.
Holt F. et al, (2024), Clin Oncol (R Coll Radiol), 36, e322 - e332
Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma.
Jones DA. et al, (2023), Clin Oncol (R Coll Radiol), 35, 301 - 310
Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.
Ntentas G. et al, (2022), Int J Radiat Oncol Biol Phys, 112, 913 - 925
Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry.
Jones DA. et al, (2022), Blood Adv, 6, 909 - 919
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma.
Cutter DJ. et al, (2021), J Clin Oncol, 39, 3591 - 3601
Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010-2020.
Duane FK. et al, (2021), Radiother Oncol, 164, 261 - 267
The role of motion management and position verification in lymphoma radiotherapy.
Aznar M. et al, (2021), The British journal of radiology, 94
Dose-response relationships for radiation-related heart disease: Impact of uncertainties in cardiac dose reconstruction.
Ntentas G. et al, (2020), Radiother Oncol, 153, 155 - 162
Cardiac Radiation Dose Reconstruction in the Study of Late Effects: A Comparison of Different Methods
Ntentas G. et al, (2018), RADIOTHERAPY AND ONCOLOGY, 127, S1091 - S1092